person · Reporting owner

Steeves Richard Martin

Disclosed activity across 2 companies

Tapewire entity: 88364
SEC CIK: 0001657245

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
STERIS plcSTE · Entity 3228	Director	August 08, 2024	August 12, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

STERIS plc

Report date August 08, 2024 · Filed August 12, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $239.68 · Expires 2034-08-08	Direct	1,389	Reported balance After 2024-08-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-08-08 · Grant · Acquired 1,389 · Balance 1,389 F1: These nonqualified stock options are fully vested and are exercisable immediately.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $239.68 · Expires 2034-08-08	Direct	1,564	Reported balance After 2024-08-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-08-08 · Grant · Acquired 175 · Balance 1,564 F2: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1: These nonqualified stock options are fully vested and are exercisable immediately.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	8,705	Reported balance After 2024-08-08 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-08-08 · Grant · Acquired 495 · Balance 8,705 F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	9,063	Reported balance After 2024-08-08 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2024-08-08 · Grant · Acquired 358 · Balance 9,063 F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000. F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Filing footnotes · ownership attribution and instrument terms

F1: These nonqualified stock options are fully vested and are exercisable immediately.

F2: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000.

F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

F5: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	Direct	Reported balance After 2019-03-28 transaction · row 1 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 9,362 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Ordinary Shares,10 pence par valueSEC Table I · non-derivative	IndirectSee Footnote Below.	Reported balance After 2019-03-28 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 319,557 · Balance 0 F2: These ordinary shares are held in a trust. F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Ordinary Shares,10 pence par valueSEC Table I · non-derivative	IndirectSee Footnote Below.	Reported balance After 2019-03-28 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 207,550 · Balance 0 F3: These ordinary shares are held by the reporting person's spouse. F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 3,781 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 4,058 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 436 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Career Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 3,593 · Balance 0 F7: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F2: These ordinary shares are held in a trust.

F3: These ordinary shares are held by the reporting person's spouse.

F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 28, 2019 Filed Jun 11, 2019 20:23 UTC Amendment	STERIS plc STE · Entity 3228	GrantOrdinary Shares	27,919	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-036085 · doc4a.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 27,919 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · balance_after: These ordinary shares are held by the Reporting Person's spouse. Excludes 179,631 shares reported on the Form 4 as beneficially owned indirectly by the Reporting Person's spouse. A corresponding inaccuracy was reported in the Reporting Person's Form 4 filing of November 2, 2015, as amended March 7, 2018, with respect to the issuer's predecessor. F3 · ownership.nature: These ordinary shares are held by the Reporting Person's spouse. Excludes 179,631 shares reported on the Form 4 as beneficially owned indirectly by the Reporting Person's spouse. A corresponding inaccuracy was reported in the Reporting Person's Form 4 filing of November 2, 2015, as amended March 7, 2018, with respect to the issuer's predecessor. Read SEC document
March 28, 2019 Filed Jun 11, 2019 20:23 UTC Amendment	STERIS plc STE · Entity 3228	GrantOrdinary Shares	188,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-036085 · doc4a.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,000 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · balance_after: Excludes 993 shares previously reported on a Form 4 filing made March 28, 2019 (the "Form 4"), which shares should not have been reported because they were not beneficially owned by the Reporting Person. Also includes 179,631 shares reported on the Form 4 as beneficially owned indirectly by the Reporting Person's spouse that were instead beneficially owned directly by the Reporting Person. Corresponding inaccuracies were reported in the Reporting Person's Form 4 filing of November 2, 2015, as amended March 7, 2018, with respect to the issuer's predecessor. Read SEC document
August 09, 2018 Filed Aug 10, 2018 16:35 UTC	STERIS plc STE · Entity 158792	GrantCareer Restricted Stock Units · Derivative	1,634	$0.00	$0.00	Disclosure SEC source: 0001209191-18-046237 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,593 Underlying: Ordinary Shares · 1,634 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 09, 2018 Filed Aug 10, 2018 16:35 UTC	STERIS plc STE · Entity 158792	GrantDirector Stock Option (right to buy) · Derivative	436	$0.00 Strike: $114.74	$0.00	Disclosure SEC source: 0001209191-18-046237 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
March 05, 2018 Filed Mar 7, 2018 16:30 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	58,953	$91.00	$5,364,723.00	Disclosure SEC source: 0001209191-18-017734 · doc4.xml · nonDerivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 0 F3 · ownership.nature: These ordinary shares are held in a self invested personal pension plan. Read SEC document
September 08, 2017 Filed Sep 12, 2017 16:40 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 10 pence par value	156,072	$87.13	$13,598,288.04	Disclosure SEC source: 0001209191-17-052443 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,362 F1 · price: The price reported in Column 4 represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $87.00 to $87.29. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document
August 09, 2017 Filed Aug 11, 2017 16:37 UTC	STERIS plc STE · Entity 158792	GrantCareer Restricted Stock Units · Derivative	1,014	$0.00	$0.00	Disclosure SEC source: 0001209191-17-048608 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959 Underlying: Ordinary Shares · 1,014 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document
August 09, 2017 Filed Aug 11, 2017 16:37 UTC	STERIS plc STE · Entity 158792	GrantDirector Stock Option (right to buy) · Derivative	4,058	$0.00 Strike: $86.23	$0.00	Disclosure SEC source: 0001209191-17-048608 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document
September 07, 2016 Filed Sep 7, 2016 17:03 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 0.10 Nominal Value	47,742	$71.20	$3,399,230.40	Disclosure SEC source: 0001209191-16-140431 · doc4.xml · nonDerivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 319,557 F1 · ownership.nature: These ordinary shares are held in a trust. Read SEC document
September 06, 2016 Filed Sep 7, 2016 17:03 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 0.10 Nominal Value	103,422	$71.28	$7,372,147.69	Disclosure SEC source: 0001209191-16-140431 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 367,299 F1 · ownership.nature: These ordinary shares are held in a trust. Read SEC document
September 02, 2016 Filed Sep 7, 2016 17:03 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 0.10 Nominal Value	48,836	$71.00	$3,467,356.00	Disclosure SEC source: 0001209191-16-140431 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 470,721 F1 · ownership.nature: These ordinary shares are held in a trust. Read SEC document
September 02, 2016 Filed Sep 7, 2016 17:03 UTC	STERIS plc STE · Entity 158792	SaleOrdinary Shares, 0.10 Nominal Value	4,778	$70.99	$339,190.22	Disclosure SEC source: 0001209191-16-140431 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,434 Read SEC document
November 02, 2015 Filed Mar 7, 2018 16:21 UTC Amendment	STERIS plc STE · Entity 158792	GrantOrdinary Shares, 10 pence par value	58,953	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-017725 · doc4a.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 58,953 F1 · shares: The original filing erroneously reported an incorrect number of shares held in the self invested personal pension plan. The Form 4 filed 11/02/2015 listed 57,962 shares, when it should have been 58,953 shares. F2 · price: Represents ordinary shares of STERIS plc ("New STERIS") acquired pursuant to New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law (the "Merger"). At the effective time of the Merger, each ordinary share of Synergy Health plc was cancelled and converted into the right to receive 0.4308 New STERIS ordinary shares. F1 · balance_after: The original filing erroneously reported an incorrect number of shares held in the self invested personal pension plan. The Form 4 filed 11/02/2015 listed 57,962 shares, when it should have been 58,953 shares. F3 · ownership.nature: These ordinary shares are held in a self invested personal pension plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.